. Glucocorticoid impairs growth of kidney outer medulla and accelerates loop of Henle differentiation and urinary concentrating capacity in rat kidney development.
contrast, early exposure of the fetus to glucocorticoid leads to pathological changes in kidneys with a reduced number of glomeruli, cysts, and development of hypertension in adult animals, referred to as "programming" of adult hypertension (4, 24, 25, 29, 35) . Preterm children treated postnatally with glucocorticoid display elevated blood pressure at an early age (14) . Thus subnormal glucocorticoid exposure is mandatory for normal intra-and early extrauterine stages of rodent kidney development, whereas a rise in glucocorticoid to the normal adult level is essential for maturation of renal medullary function in later developmental stages after nephron formation. Little information is available about the effect of glucocorticoid on kidney growth and differentiation just after nephrogenesis has finished. After the surge at parturition, circulating glucocorticoids are at a nadir in the second postnatal week in rodents coincident with marked expansion of the renal medulla (5, 16, 13, 20) . Thus only short-loop nephrons exist at birth (5, 16) . Before maturation of urinary concentrating ability, loops of Henle undergo considerable elongation to achieve the adult conformation in the second and third postnatal weeks. This occurs through mitotic activity and apoptosis in descending and ascending limbs (5, 22, 33) . It is unknown whether proliferation of cells in Henle's loop at this stage depends on low circulating glucocorticoid and whether proliferating cells are undifferentiated. Glucocorticoid increases concentrating ability at weaning (27) , and elevated extracellular osmolality is genotoxic and may hamper cell proliferation (6, 18) . This is one mechanism by which supranormal glucocorticoid potentially disturbs cell proliferation. The relevance of these in vitro observations for proliferation of Henle's loop in the renal medulla in vivo has not previously been examined.
In the present study, we determined changes in thick ascending limb (TAL)-associated cell proliferation and NaCl transport proteins in a postnatal period that covered the interval with maximal changes of endogenous glucocorticoid (13, 20) . Moreover, we supplemented rats with glucocorticoid in a postnatal developmental "window" after nephrogenesis where endogenous plasma glucocorticoid is low and proliferation is intense [postnatal (P) days 8 -12] . We explored the effect of "precocious" glucocorticoid on NaCl transporters, cell proliferation, apoptosis, and urinary concentrating ability. We tested the hypothesis that glucocorticoid enhances urinary concentrating ability but exerts negative effects on mitotic activity, induces a DNA damage response, and accelerates apoptotic cell death in medullary cells.
MATERIALS AND METHODS

Animal Experiments
All in vivo experiments and animal handling were approved by the Animal Experimentation Inspectorate under the Danish Ministry of Justice and were in accordance with the published guidelines from the National Institutes of Health. Female Sprague-Dawley rats used for breeding had free access to standard pathogen-free rat chow [Altromin-1310, Lage, Germany, Na ϩ (2 g/kg), Cl Ϫ (5 g/kg)] and tap water. The dams and pups were housed with a 12:12-h light-dark cycle at 20°C until weaning at 3 wk (P21) of age.
Developmental series. We examined rat pups at developmental stages that covered the period of maximal changes in endogenous glucocorticoid: the birth peak (P0), nadir at days 8 -12 , and the 10-to 15-time increase at weaning on day 21 (13, 20) . Pups were decapitated, and trunk blood was collected in EDTA-coated tubes and plasma was isolated by centrifugation and stored at Ϫ20°C. The kidneys were snap-frozen in liquid nitrogen and stored at Ϫ80°C. For immunohistochemistry, rats were anesthetized with intraperitoneal injections of pentobarbital sodium (mebumal, 50 mg/kg) and perfusion fixed with 4% phosphate-buffered paraformaldehyde for 4 min through the left cardiac ventricle at P2-P20. Kidneys were fixed for 4 h, then trimmed in coronal blocks with the papilla, washed in PBS, dehydrated, and then paraffin-embedded.
Glucocorticoid series. Litters were reduced to the sex-matched size of 10 pups at the day of birth (n ϭ 3 litters). Intervention started at the nadir of endogenous glucocorticoids, P8 (13) . At P8, rats were divided into four groups receiving either high-dose dexamethasone [DEXA; 100 g ⅐ kg Ϫ1 ⅐ day Ϫ1 (Decadron, 4 mg/ml, Merck)]; lowdose DEXA (10 g ⅐ kg Ϫ1 ⅐ day Ϫ1 ); mifepristone, a glucocorticoidreceptor antagonist (5 mg ⅐ kg Ϫ1 ⅐ day Ϫ1 , Sigma); or vehicle (0.9% saline or sesame oil) once daily by subcutaneous injections. DEXA was diluted in isotonic saline, and all rats were injected with 5 l/g. After 5 days of treatment, rats were decapitated, and blood, urine, and kidneys were collected as described above. Urine osmolality was determined by freeze-point depression (Osmomat 030-D, Gonotec, Bie and Berntsen) of 50-l samples. Na and K concentration was determined by flame photometry (model IL 943, Instrumentation Laboratory, Lexington, MA). In another series (n ϭ 1 litter with 11 pups), rats were treated continuously from P1 to P11 with DEXA (100 g ⅐ kg Ϫ1 ⅐ day Ϫ1 ) or vehicle (isotonic saline), and kidneys were perfusion fixed for morphological analysis as described below.
Fluid deprivation series. Three litters of 10 sex-matched pups were given either high-dose DEXA (100 g ⅐ kg Ϫ1 ⅐ day Ϫ1 ) or vehicle (0.9% saline) in 5 l/g once daily from P8 to P12. On P11, the rats were removed from the dams for 12-14 h. Rat pups at P12 do not urinate spontaneously (29) . Pups voided by the gentle striking of the pubic region accompanied by application of suprapubic pressure after 6 h. Urine was collected again after 12 h when the pups were decapitated. Four pups from each group were left for additional 3 h (15 h in total), and then the pups were anesthetized with an intraperitoneal injection of pentobarbital sodium (mebumal, 50 mg/kg), and the urine was collected directly from the bladder before perfusion fixation.
mRNA Assays
Whole kidneys were used for isolation of total RNA with midi-or mini-RNeasy columns (Qiagen, Albertslund, Denmark) according to the manufacturer's instructions. RNA was quantified by spectrophotometry and stored at Ϫ80°C. RNA was analyzed by ribonuclease protection assay as described previously (1) or by quantitative PCR. For both assays, PCR amplification of cDNAs was performed with primer sets shown in Table 1 (Invitrogen). PCR products were cloned in vector pSP73 as described previously (1) . cDNA was obtained by reverse transcription of 1 g total RNA (iScript cDNA synthesis kit, Bio-Rad). Cloned cDNAs were sequenced (Applied Biosystems). Plasmids carrying cDNA inserts were linearized with HindIII and used as a template for synthesis of radiolabeled antisense RNA probes (1) or as standards for real-time quantitative PCR after serial dilution. For quantitative PCR, 50 ng cDNA in duplicate were used as a template and mixed with the respective primers ( Table 1 ) and iQ-SYBR Green Supermix (Bio-Rad) in a final volume of 25 l. The mixture was denatured for 3 min at 95°C, and 44 cycles were run on an iQ-Thermocycler (Bio-Rad) as follows: denaturation, 30 s at 95°C, and annealing and extension, 45 s at 60°C. The standard curve was constructed by plotting threshold cycle (C t values) against serial dilutions of the linearized plasmid (10 Ϫ9 -10 Ϫ15 g). Specificity was established postrun for each plate setup by melting curve analysis. Random samples from each plate were loaded on agarose gels to confirm the amplification product. Plasmids for generating probes for Na/H exchanger type 3 (NHE3), renin, and ␤-actin have previously been validated (1, 23) .
Western Blotting
Proteins were isolated from kidney tissue by homogenization of tissue for 30 s in buffer [100 mM Tris ⅐ HCl, pH 7.2, 10 mM EDTA, 1 mM DTT, and 0.1% Triton X-100, containing a complete protease inhibitor tablet (Roche)/10 ml homogenization buffer]. After 10-min incubation on ice, the samples were centrifuged at 10,000 g for 10 min at 4°C. For determination of Na-K-2Cl cotransporter (NKCC2), freshly dissected tissue was homogenized in a sucrose-imidazole buffer [0.3 M sucrose, 25 mM imidazole, 1 mM EDTA, pH 7.2, with protease inhibitors (0.02 M leupeptin, 0.4 M pefabloc) and phosphatase inhibitors (0.2 M ortho-vanadate, 0.2 M NaF, and 0.082 g/l okadaic acid)]. Cell debris was removed by centrifugation of the samples for 15 min at 4,000 g at 4°C. Protein concentration of the supernatants was determined by spectrometry according to the Bradford method (Bio-Rad protein assay reagent) using BSA as a standard. Aliquots (20 -40 g) were denatured for 5-10 min at 95°C, separated on a 4 -12% PAGE gel, and blotted on to a polyvinylidene difluoride membrane. An additional gel was run in parallel and stained with simple blue (Bio-Rad) to ensure uniform loading. The membranes were blocked over night with 5% dry milk in TBST (20 mM Tris ⅐ HCl, 137 mM NaCl, 0.05% Tween 20, pH 7.6) and then incubated with the specific primary antibody appropriately diluted for rabbit anti-NKCC2 (1:2,000, Chemicon), rabbit anti-ROMK (1:2,000, Alomone), rabbit anti-Na-K-ATPase-␣ 1 (1:1,000, Upstate), rabbitanti-PCNA (1:2,000, Santa Cruz Biotechnology), and rabbit anti-GADD153 (1:500, Santa Cruz Biotechnology). After additional washes in TBST, the membranes were incubated with horseradish peroxidase (HRP)-conjugated goat anti-rabbit antibody (DAKO) diluted 1:2,000 in 5% milk-TBST for 1 h and visualized with an ECL chemiluminescence detection kit (Amersham). The relative densities of immunoreactive protein bands were evaluated by QuantityOne software (Bio-Rad).
Immunohistochemistry and Morphometry
Coronal sections through all regions including the tip of the papilla (4 m) were prepared for immunostaining as previously described (32) . Some antigens required retrieval by boiling for 20 min in either 10 mM citrate buffer, pH 6, or TEG buffer (100 mM Tris ⅐ HCl, pH 9, 10 mM EGTA). The sections were blocked for 1 h in 5% milk TBST, then incubated overnight at 4°C with primary antibodies diluted in 5% milk-TBST: anti-ROMK (1:500), anti-NKCC2 (1:1,000), anti-Na-KATPase-␣ 1 (1:100), PCNA (1:100), and sheep anti-Tamm-Horsfall glycoprotein (THP; 1:200, Upstate). The following day, the sections were washed and incubated for 1 h with HRP-conjugated goat antirabbit antibody or HRP-conjugated rabbit anti-sheep antibody (DAKO) diluted 1:1,000 in 5% milk-TBST. The immunolabeling was visualized by incubation with 0.01% diaminobenzidine and 0.02% H 2O2 for 1-20 min. A negative control with omission of primary antibody was always run in parallel. After antigen retrieval by heating for 5 min in a pressure cooker, GADD153 labeling (1:1,000) was performed with the CSA-labeling amplification system (DAKO) according to instructions. A series of negative controls was performed: a primary antibody was incubated overnight at 4°C with 20 g/ml peptide used for immunization and applied to the tissue sections and amplified exactly as described above; primary antibody was omitted and reacted as above; and, finally, an anti-rabbit secondary antibody (DAKO) instead of a primary antibody was applied and reacted. For double-labeling experiments for PCNA and THP, the basic procedure was as described above. The secondary Alexa Fluor 488-conjugated donkey anti-sheep (1:300, Molecular Probes) and Alexa Fluor 568-conjugated goat anti-rabbit antibodies (1:100, Molecular Probes) were incubated in the dark for 1 h and inspected with an Olympus BX51 microscope. Photos were captured with a Olympus DP50 camera and processed using Photoshop 6.0. For morphometry, kidney sections labeled for THP and NKCC2 were photographed and compound pictures of whole sections were produced using Corel Draw. Kidney cortex, outer medulla, and papilla area and thickness were determined by defining a field extending from a line between juxtamedullary glomeruli (cortex-outer medullary border) to a line that connects points where THP-and NKCC2-positive TALs disappear (outer medullary-inner medullary junction). PCNA-positive nuclei were counted within this area with the aid of Image Tool version 3.0 (National Institutes of Health).
Osmolality, Na ϩ , and Urea Concentration in Papillary Tissue
Papillas were snap-frozen in liquid nitrogen. Osmolytes were extracted using a protocol from Kusano et al. (19) . Papillas were weighed and vacuum dried until the weight had stabilized (2.5 h, difference was taken as water content), boiled in 150 l ultrapure water in a water bath for 1 h, and centrifuged for 10 min at 13,000 g. The osmolality of the supernatants was measured by freeze-point depression (Osmomat 030-D, Gonotec, Bie & Berntsen), and sodium and potassium were measured by flame photometry (IL 943, flame photometer, Instrumentation Laboratory). Urea content was determined kinetically as the amount of NADH used over time measured by spectrometry (340 nm) after hydrolysis of urea by urease and formation of L-glutamate by glutamate dehydrogenase (ABX Pentra Urea CP, ABX Diagnostics).
Detection of Apoptosis
Apoptotic cells were identified in kidney sections using an immunohistochemical approach that recognizes DNA double-strand breaks [transferase-mediated dUTP nick-end labeling (TUNEL) technology]. The procedure was performed in accordance with the manufacturer's instructions (in situ cell death detection kit, Roche).
Statistics
All values are presented as means Ϯ SE. We found no variations with gender in any of the analyzed data sets, and data were pooled. For multiple comparisons, one-way ANOVA was performed. When there was a significant difference between the groups in sets of data, a post hoc test by unpaired Student's t-test with Bonferroni's correction was used. Two groups were compared with an unpaired Student's t-test. P Ͻ 0.05 was considered statistically significant.
RESULTS
Localization and Quantification of Proliferating Cells in the Developing Kidney
At P2, immunoreactivity for PCNA was associated with cell nuclei in the nephrogenic zone (not shown), and at P7 weak labeling for PCNA was observed in the nephrogenic zone but also appeared in tubular cells, always restricted to nuclei, at the border between the cortex and outer medulla (Fig. 1A) . A shift in localization appeared at P10, when PCNA immunoreactivity increased in intensity and accumulated in medullary rays in the juxtamedullary cortex and tubules in the outer stripe of outer medulla (Fig. 1A) . At P21, PCNA-positive cells were observed predominantly in the kidney cortex and exhibited an even distribution (Fig. 1A) . PCNA immunoreactivity was scarce in the inner medulla and papilla at all stages (not shown). Western blotting for PCNA using whole kidney protein showed that PCNA abundance in adult animals (P56) was 7-8% of the level at birth (P0, Fig. 1B ). Of note, PCNA decreased most markedly after weaning between P21 and P56 (n ϭ 2-3 at each stage, Fig. 1B ). Serial sections of kidney at P10 showed that the majority of PCNA-positive cells in medullary rays displayed apical labeling for NKCC2 (Fig. 1C) . At P10, double labeling for PCNA (red) and the TAL marker THP (green) showed that the majority of PCNA-positive cells were coexpressed with THP (Fig. 2C) . Not all proliferating cells in medullary rays colocalized with THP, indicating either undifferentiated TAL cells or cells in non-TAL segments (5).
Effect of DEXA on Cell Proliferation, Apoptosis, and DNA Damage Proteins in Kidney During Postnatal Development
Body weight gain in response to DEXA treatment was 2.3 Ϯ 0.6 g (P ϭ 5.7 ϫ 10 Ϫ5 compared with control) and 5.7 Ϯ 0.7 g (P ϭ 0.021 compared with control) in the two treatment groups (control pups 8.6 Ϯ 0.8 g). Mifepristone (5 mg/kg) did not change body weight gain between P8 and P12 (9.4 Ϯ 0.9 g, P ϭ 0.53 compared with control, n ϭ 7-8 pups/condition in 3 litters). Total kidney mass was not significantly changed by DEXA treatment from P8 to P12 (287 Ϯ 7.7 and 305 Ϯ 4.6 mg in DEXA groups, respectively, and 304 Ϯ 12.8 mg in mife-pristone vs. 298 Ϯ 5.3 mg in controls, n as above). Thus the kidney weight-to-body weight ratios were significantly increased in response to DEXA (12.5 Ϯ 0.3 mg/g, P ϭ 0.011 and 13.7 Ϯ 0.5 mg/g, P ϭ 0.001) compared with controls (11.0 Ϯ 0.3 mg/g) and mifepristone (10.9 Ϯ 0.3 mg/g, P ϭ 0.87 vs. control).
PCNA abundance decreased after DEXA when measured in whole kidney homogenate and in the deep cortex-outer stripe of outer medulla fraction (Fig. 2, A and B, n ϭ 5-6 ). Both the area of distribution and the intensity of PCNA labeling appeared decreased compared with control kidneys (Fig. 2B) . PCNA-immunopositive nuclei were very rarely observed in the inner medulla in all conditions (Fig. 2B) . After DEXA treatment, the majority of PCNA-positive cells in the outer medulla still colocalized with THP (Fig. 2C, right, n ϭ 2) .
In kidney sections from control pups, labeling for apoptosis by TUNEL reaction yielded very few positive cell nuclei and apoptotic bodies scattered primarily in the inner medulla near the border to the outer medulla (Fig. 3A) . After DEXA, the number of TUNEL-positive nuclei increased within the inner medulla (Fig. 3A) . TUNEL-labeled cells were observed in bending tubules (Fig. 3A) , most likely thin limbs of Henle's loop because they did not colocalize with THP-positive cells (not shown). At P12, the urea-inducible growth-arrest and DNA damage protein GADD153 was associated with the nuclei of collecting ducts, interstitial cells, and loop of Henle cells (Fig. 3B) . GADD153 immunoreactivity was strongest in the inner medulla (Fig. 3B) . After DEXA treatment, GADD153
immunolabeling was more intense particularly in the inner medulla (Fig. 3B, right) . Preabsorption of GADD153 antibody with peptide used for immunization prevented immunolabeling (not shown). Western blotting for GADD153 confirmed that GADD153 abundance was enhanced after DEXA (Fig. 3B , n ϭ 5). As previously published (38) , GADD153 immunoblotting produces a slower-migrating nonspecific band (Fig. 3B ) that was not changed by experimental conditions.
Effect of Prolonged DEXA on Postnatal Kidney Development
Administration of DEXA through P1-11 resulted in a significantly shorter corticomedullary axis (control 4.6 Ϯ 0.2 mm, n ϭ 3 vs. DEXA 3.8 Ϯ 0.4 mm, n ϭ 4, P Ͻ 0.04). Labeling for THP was used to delineate the borders between the outer and inner medulla in morphometric analysis of coronal sections (Fig. 4A) . DEXA did not change the area (5.9 Ϯ 0.5 vs. 5.6 Ϯ 0.6 mm 2 ) or thickness (0.69 Ϯ 0.05 vs. 0.63 Ϯ 0.01 mm) of the cortex. DEXA also had no effect on the length (2.7 Ϯ 0.2 vs. 2.9 Ϯ 0.1 mm, from tip to base) or area of the inner medulla (2.8 Ϯ 0.2 vs. 3.2 Ϯ 0.07 mm 2 ). In contrast, DEXA treatment significantly reduced the area and thickness of the renal outer medulla (Fig. 4, A and B) . DEXA reduced significantly the number of PCNA-positive cell nuclei in the outer medulla (Fig.  4B) . To exclude the possibility that a change in THP labeling by DEXA caused the effect on outer medullary growth, all kidney sections were labeled for TAL-specific NKCC2. NKCC labeling yielded that same pattern of intrarenal distribution (not Fig. 1 . A: distribution of proliferating-cell nuclear antigen (PCNA) in kidney through postnatal (P) developmental stages. PCNA was associated with cell nuclei at all analyzed stages of development. At P7, the nephrogenic zone displayed signals, whereas signals in more mature tubules were scarce. At P10, PCNA signal shifted to medullary rays in cortex and tubules at the corticomedullary junction in outer medulla. At weaning (P21), PCNA-positive cells were fewer and scattered across cortex and outer medulla. Scale bars ϭ 200 m. B: Western blot analysis for PCNA using whole kidney protein revealed a band at expected size at 35 kDa (n ϭ 2 at each stage). Columns represent average densitometric units at each stage. C: serial sections of kidney at P10 labeled for PCNA (a) and Na-K-2Cl cotransporter (NKCC2; aЈ). NKCC2 and PCNA were not mutually exclusive. Arrowheads point at 3 typical cells positive for both PCNA and NKCC2. Scale bars ϭ 50 m.
shown). The use of these markers is not likely to result in underestimation of outer medullary dimensions.
Effect of DEXA from P8 to P12 on Urinary Concentrating Ability
Osmolality of spot urine at P12 was 347 Ϯ 32 mosmol/kgH 2 O (n ϭ 6, Fig. 5A ). In response to both doses of DEXA, spot urine osmolality increased (Fig. 5A shows the effect of 100 g/kg, n ϭ 6, control, n ϭ 8). Mifepristone (5 mg⅐kg Ϫ1 ⅐day Ϫ1 ) had no effect on urine osmolality at P12 compared with control (380 Ϯ 9 mosmol/kgH 2 O, n ϭ 7 vs. 347 Ϯ 32 mosmol/kgH 2 O, n ϭ 7, not shown). Water deprivation (12 h) caused an increase in urine osmolality compared with hydrated rats (Fig. 5A) . Additional dehydration for 3 h on an empty bladder did not increase urine osmolality compared with 12 h (Fig. 5A) . Water deprivation of DEXA-treated rats increased urine osmolality significantly after 12 and 15 h compared with water-deprived, vehicle-injected pups and DEXA-treated, hydrated rats (Fig. 5A) . The papillary water content was determined to be 86 Ϯ 0.5% (n ϭ 10) in hydrated pups and 76 Ϯ 1% (n ϭ 8) after fluid deprivation. Papillary interstitial osmolality in control pups at P12 was 537 Ϯ 27 mosmol/kgH 2 O (n ϭ 4, Fig. 5B ). DEXA increased papillary osmolality significantly (Fig. 5B) . Water deprivation did not augment papillary osmolality significantly in control pups or DEXA-treated pups (Fig. 5B) . There was not equilibrium between spot urine osmolality and papillary osmolality in control pups (Fig. 5, A and B) . After dehydration, equilibrium was reached (urine: 568 Ϯ 17 mosmol/kgH 2 O, n ϭ 15; papilla: 565 Ϯ 23 mosmol/kgH 2 O, n ϭ 5). DEXA led to equilibrium between interstitium and urine in hydrated rats (papilla 728 Ϯ 48 mosmol/kgH 2 O, n ϭ 4 vs. 614 Ϯ 84 mosmol/kgH 2 O, n ϭ 8, P ϭ 0.32, Fig. 5, A and B) and to equilibrium after dehydration (papilla 754 Ϯ 70 mosmol/kgH 2 O, n ϭ 5 vs. 809 Ϯ 40 mosmol/kgH 2 O, n ϭ 14, P ϭ 0.49). Urea concentration was significantly higher in papillary interstitial fluid after DEXA in hydrated and water-deprived rats (Table 2) . There was no statistically significant difference in sodium and potassium concentrations (Table 2) . Renal mRNA levels for the organic osmolyte transporters sodium-dependent myo-ino- , P8-P12) on PCNA. A: Western blots for PCNA in whole kidney (left, n ϭ 5-6) and in deep cortex-outer stripe fraction (right, n ϭ 6). OD, optical density. *P Ͻ 0.05, DEXA compared with control. B: effect of DEXA (100 g ⅐ kg Ϫ1 ⅐ day Ϫ1 , P8-P12) on intrarenal distribution of immunoreactive PCNA protein. Histochemical PCNA signal is seen without counterstain. PCNA immunoreactivity was less widely distributed and less intense in response to DEXA (right). Scale bars ϭ 200 m. C: double labeling of control kidney (P12, left) and DEXAtreated kidney (P12, right) for PCNA (red) and the thick ascending limb marker Tamm-Horsfall glycoprotein (THP; green). The vast majority of PCNApositive cells were associated with the thick ascending limb in both conditions. Scale bars ϭ 50 m. sitol transporter (SMIT) and betaine-␥-amino-N-butyric acid transporter (BGT-1) were significantly elevated in response to DEXA (100 g⅐ kg Ϫ1 ⅐day
Ϫ1
, Fig. 5C ).
Developmental Regulation and Effect of DEXA on TALAssociated Sodium and Chloride Transport Molecules
Ribonuclease protection assays were linear, at least in the range 10 -40 g of total RNA, and the hybrids and probes displayed the expected molecular sizes (data not shown). There were significant developmental increases in mRNA levels of the TAL-associated transporters ROMK, NHE3, and Na-KATPase ␣ 1 -subunit between P7 (when circulating glucocorticoids are at nadir) and P21 (Fig. 6A) . After weaning, transport molecule mRNAs remained stable or decreased slightly at P28 and P56 (data not shown). NKCC2 was developmentally regulated and increased significantly between P0 and P21 (Fig.  6A) , followed by stabilization at P28 and P56 (data not shown). ClCK2 mRNA expression was not developmentally regulated. Many "housekeeping" genes are developmentally regulated, and we used renin as a "biological" RNA control that is known to be downregulated during development. Renin mRNA changed inversely with development ( Fig. 6A) (10, 31) . The differential regulation of renin and NaCl transporters suggests that the changes are not caused by variation in RNA quality (Fig. 6A) . Moreover, Western blot analysis confirmed that NKCC2 protein increased significantly between P7 and P21 and migrated as a band of 150 kDa (Fig. 6B, n ϭ 3-4) . Na-K-ATPase ␣ 1 -subunit protein migrated as a band of 110 kDa and increased between P7 and P21 (Fig. 6B, n ϭ 3-4) . ROMK appeared as two distinct bands, one ϳ40 kDa, which corresponds to the theoretic size, and a product of unknown significance at 90 kDa (not shown), which has been found by several other investigators (9, 36) . The 40-kDa protein significantly increased between P7 and P21 (Fig. 6B, n ϭ 3-4) . For all blots, a gel was run in parallel and proteins were stained with simple blue (Bio-Rad) to ensure uniform loading and migration (not shown). Immunohistochemical staining showed that NKCC2-immunoreactive protein was at the limit of detection in cross sections of the renal outer medulla at P2 (Fig. 6C) . At P10, NKCC2 labeling was more intense and more widely distributed along the apical aspect of tubules within medullary rays in the cortex and was especially marked in the outer medulla (Fig. 6C) . At P21, strong and uniform NKCC2 immunoreactivity was localized in the apical membrane of the medullary and cortical TAL cells (Fig. 6C) .
Renal mRNA levels of NKCC2, ROMK, Na-K-ATPase ␣ 1 -subunit, and NHE3 were significantly increased by DEXA (100 g⅐kg Ϫ1 ⅐day Ϫ1 ) compared with vehicle-injected controls (Fig. 7A, n ϭ 7-8) . At low-dose DEXA (10 g⅐kg Ϫ1 ⅐day Ϫ1 ), there were no significant changes (not shown). There was no effect of mifepristone treatment on the analyzed renal transporters at this stage of development (data not shown). ␤-Actin mRNA abundance was significantly lowered in response to Values are means Ϯ SE expressed as mmol/kgH2O; n ϭ 4 hydrated rats and n ϭ 5 dehydrated rats. Water content of the papilla was 86 Ϯ 0.5% (n ϭ 10) in hydrated pups and 76 Ϯ 1% (n ϭ 8) in water-deprived pups. *P Ͻ 0.05, control compared with dexamethasone treatment by unpaired Student's t-test. ⅐ day Ϫ1 at P8-P12) on osmolality of spot urine and urine collected after water deprivation. Histogram shows average value of 6 -8 determinations. *P Ͻ 0.05 compared with vehicle treatment. #P Ͻ 0.05 compared with hydrated rats. B: effect of DEXA (100 g ⅐ kg Ϫ1 ⅐ day Ϫ1 at P8-P12) on papillary interstitial osmolality in control pups (n ϭ 4) and water-deprived pups (12 h, n ϭ 5). *Significant difference (P Ͻ 0.05) between controls and DEXA. C: effect of DEXA (100 g ⅐ kg Ϫ1 ⅐ day Ϫ1 at P8-P12) on osmolyte transporter mRNAs. Messenger RNA level was determined for betaine ␥-amino-N-butyric acid transporter type 1 (BGT1) and Na ϩ -myoinositol transporter (SMIT) by quantitative real-time PCR using total RNA from whole kidneys (n ϭ 7-8). TATA box binding protein (TBP) was amplified as a reference gene. Values are normalized for TBP. SQ, starting quantity of cDNA. *P Ͻ 0.002, DEXA compared with control.
both doses of DEXA as reported previously (32) (Fig. 7A) . The inverse change in NaCl transporter mRNAs and ␤-actin mRNA indicates specific responses to DEXA treatment and not a general difference in RNA quality or loading. Experiments in whole kidney homogenate confirmed that Na-K-ATPase ␣ 1 -subunit and NKCC2 protein levels increased significantly by DEXA (100 g⅐kg Ϫ1 ⅐day
Ϫ1
) compared with control (Fig. 7B , n ϭ 5-6/ condition). ROMK protein abundance was not affected significantly by DEXA treatment (Fig. 7B , n ϭ 5-6). Immunohistochemical labeling showed that NKCC2-immunoreactive protein distribution changed after DEXA. NKCC2 immunoreactivity was more intense and uniformly associated with apical membranes of TAL cells in cortical medullary rays and the outer medulla (Fig. 7C ). Gels with similar amounts of protein loaded as used for Western blots always ran in parallel to ensure uniform loading by simple blue staining. *P Ͻ 0.05. C: cellular distribution of NKCC2 immunoreactive protein in kidney investigated at the indicated postnatal days. At P21 (weaning), NKCC2 protein was uniformly associated with apical membrane, whereas labeling was less pronounced at earlier stages. Scale bars ϭ 50 m.
DISCUSSION
The present study shows that brief exposure of rat kidney to a synthetic glucocorticoid receptor agonist (DEXA) in the suckling period (P8-P12) accelerates loop of Henle differentiation but inhibits cell proliferation in the TAL. Continuous exposure of the kidney to DEXA from birth to P11 selectively impairs development of renal outer medulla. DEXA converts the TAL epithelium to an adultlike phenotype and increases papillary tonicity, which, together with increased water permeability in the collecting duct, leads to an enhanced urinary concentrating capacity. It is well established that intact adrenal function is crucial for development of urinary concentrating capacity at weaning (27) and glucocorticoid supplementation increases concentrating ability only in the period before weaning and not at weaning or in adult rats (27) . An array of TAL-associated NaCl transporters are upregulated and display stronger membrane localization with postnatal development and by DEXA in preweaned developmental stages. This effect could be one pathway by which glucocorticoids stimulate urinary concentrating ability as indicated in previous studies (2, 3, 9, 11, 26, 30, 37) .
An antagonist of the glucocorticoid receptor had no effect on growth rate, urinary concentrating ability, and transporter abundance in the second postnatal week. Thus at the nadir of corticosterone (P8-P12) (13, 27, 25) , the plasma level appears to be below the threshold for exerting physiological effects on ) on whole kidney abundance of loop of Henle transport proteins. Twenty-to forty-microgram protein aliquots were used for the assays (n ϭ 5-6). *P Ͻ 0.05. C: effect of DEXA (100 g ⅐ kg Ϫ1 ⅐ day
Ϫ1
, P8-P12, n ϭ 2) on renal distribution of immunoreactive NKCC2. In response to DEXA, NKCC2-immunoreactive protein was more widely distributed compared with control and displayed a uniform association with apical membranes. Scale bars ϭ 200 m.
kidney transport proteins and urinary concentrating ability. In this glucocorticoid-deficient stage of development referred to as the "stress-hyporesponsive period," the hypothalamic-pituitary-adrenal axis fails to elicit increases in ACTH and glucocorticoid when challenged, the adrenals are nonresponsive to exogenous ACTH, and the normal circadian rhythm is not established (28, 29) . Coincident with the glucocorticoid-deficient stage, proliferating cells wane in the nephrogenic zone and accumulate in loop of Henle epithelium as indicated by the markers PCNA and THP. Of note, PCNA-positive cells in medullary rays also express NKCC2, which suggests that dividing cells are differentiated. DEXA shortened the corticopapillary axis, and low glucocorticoid exposure appears especially important for development of the outer medulla. The papilla exhibited no difference in size or area after continuous exposure to DEXA. It is not resolved by the present experiments whether these morphological changes in the outer medulla are caused primarily by decreased proliferation or increased apoptotic conversion of TALs to thin ascending limbs (4, 16), or both. Moreover, it is not possible to discriminate between an indirect effect of DEXA through, e.g., elevated interstitial osmolality or impaired angiogenesis, and a direct effect. Interstitial osmolality did not increase by the short dehydration protocol applied in the present experiments. The role of osmolality in medullary growth in the absence of changes in glucocorticoid is therefore not clear. Proliferating cells were very scarce in the immature papilla at all stages, which indicates that regions with elevated interstitial osmolality and cell proliferation are mutually exclusive in the developing kidney. DEXA is a synthetic, selective glucocorticoidreceptor agonist, and the doses used were lower than in similar studies on postnatal rat kidney function with the equipotent betamethasone (27, 36) and within the range used to treat women at risk of preterm delivery. It is not possible from the present data to extrapolate the level of endogenous glucocorticoid at which similar changes in kidney function and structure occur.
DEXA increased the abundance and apical membrane association of NKCC2 and Na-K-ATPase. Previous data show that glucocorticoids enhance loop of Henle mitochondrial respiratory capacity and Na-K-ATPase activity (7, 8, 26) . Theoretically, each of these effects strengthens countercurrent amplification capacity. Indeed, DEXA raised medullary tonicity, urinary concentrating ability, and expression of the organic osmolyte transporters SMIT and BGT-1. Although "precocious" exposure to elevated glucocorticoid increased urinary concentrating ability (to ϳ800 mosmol/kgH 2 O), it did not recapitulate the increase in medullary tonicity achieved spontaneously at weaning (ϳ2,000 mosmol/kgH 2 O) (27) . The difference in absolute level of osmolality most likely reflects the incomplete elongation of Henle's loops at the early stage of P12. DEXA increased papillary tonicity by accumulation primarily of urea to a level normally encountered first at P20 (27) . This finding is in accord with upregulation of urea-inducible transcription factor GADD153 specifically in inner medullary cell nuclei. The enhanced accumulation of urea could be caused by an increase in urea transporter UTA (17) , by an increase of urea availability, and by an increased urea concentration in collecting duct fluid.
The short dehydration protocol applied in our experiments (12-15 h) led to equilibration between urinary and interstitial osmolality. The pups must have the capacity to activate aquaporins similar to later developmental stages. Water permeability of the collecting ducts is therefore not the limiting factor that causes a reduced urinary concentrating capacity at early stages of postnatal kidney development. Rather, the limited interstitial medullary gradient is responsible for a lower concentrating ability. Medullary tonicity and papillary sodium and urea content exhibit a developmental increase similar to urinary concentrating ability (27, 34) . DEXA led to equilibration between urinary and papillary tonicity in normohydrated rats, suggesting an effect of DEXA on collecting duct water permeability that is in accord with previous observations (36) .
The number of apoptotic cells in the medullary, THPnegative part of Henle's loop, was increased by DEXA. In general, apoptotic bodies were rare but have previously been found at this site and ascribed a role in the normal transformation of the TAL into thin ascending limb at the outer medullary-papillary border (16) . Exposure to DEXA and/or elevated interstitial osmolality accelerates this remodeling process further during postnatal development. The present findings could be relevant in the context of "programmed" hypertension. Thus in rats with restricted protein intake during pregnancy, NKCC2 is permanently elevated in kidneys in the postnatal period (21) . The role of glucocorticoid in this response is unknown. The present studies do not show whether termination of glucocorticoid exposure results in catch-up growth, but future studies should clarify whether adult rats exposed to glucocorticoid through late developmental stages exhibit changes in kidney morphology, function, and blood pressure regulation. In summary, we have observed that a low circulating concentration of glucocorticoid is permissive for proliferation of Henle's loop and development of the outer medulla in the postnatal stages that follow nephrogenesis and precede weaning. This occurs at the "cost" of reduced papillary tonicity, which appears as an important factor for the reduced capacity to concentrate urine during postnatal stages of kidney development.
